Block & Leviton is investigating Alignment Healthcare for potential securities law violations. On July 8, 2026, a former executive filed a whistleblower lawsuit alleging the company manipulated its finances to boost its stock price and executive compensation. The allegations follow Alignment Healthcare's report of strong first-quarter 2026 results, including sharply higher revenue, a swing to profitability, rising adjusted EBITDA, and a jump in operating cash flow, which led the company to raise its full-year guidance. After the whistleblower lawsuit was reported, Alignment Healthcare's stock price fell approximately 16.72% in a single day. Investors who purchased Alignment Healthcare securities and suffered losses may be eligible for compensation.
Alignment Healthcare LLCWhistleblower lawsuit alleging financial manipulation and securities law violations, causing stock to drop 16.72%.